« Back
Home /
Atranorin

Atranorin

Item no.	HY-N2907-10mg
Manufacturer	MedChem Express
CASRN	479-20-9
Amount	10 mg
Quantity options	10mM/1mL 10 mg 1 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Molecules
Specific against	other
Purity	99.41
Formula	C19H18O8
Citations	[1]Studzinska-Sroka E, et al. Atranorin - An Interesting Lichen Secondary Metabolite. Mini Rev Med Chem. 2017;17(17):1633-1645.<br/>[2] Zhou R, et al. The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis. Sci Rep. 2017 Aug 15;7(1):8136.
Smiles	O=C(OC1=CC(C)=C(C(OC)=O)C(O)=C1C)C2=C(C)C=C(O)C(C=O)=C2O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Available
Product Description	Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity[1][2].
StorageTemperature	-20°C, 3 years (Powder)
Shipping	Blue Ice
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	374.34
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer
Solubility	DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Target	Endogenous Metabolite; Ras
Manufacturers Target	Endogenous Metabolite; Ras
Manufacturers Pathway	GPCR/G Protein; MAPK/ERK Pathway; Metabolic Enzyme/Protease
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Request delivery time